Get started
Adagene Inc.Adagene Inc.Adagene Inc.

Adagene Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

ADAG chart

Key stats

Market capitalization
‪116.47 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.44USD
Net income
‪−18.95 M‬USD
Revenue
‪18.11 M‬USD
Shares float
‪38.11 M‬
Beta (1Y)
0.76

About Adagene Inc.

Sector
Health Technology
CEO
Pei Zhi Luo
Headquarters
Suzhou
Website
adagene.com
Employees (FY)
174
Founded
2011
ISIN
US0053291078
FIGI
BBG00YZ6BYJ6
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.